Phospho-Bad (S155) Polyclonal Antibody

BCL2 associated agonist of cell death encoded by BAD is a member of the BCL-2 family. BCL-2 family members are known to be regulators of programmed cell death. BCL2 associated agonist of cell death positively regulates cell apoptosis by forming heterodimers with BCL-xL and BCL-2, and reversing their death repressor activity. Proapoptotic activity of BCL2 associated agonist of cell death is regulated through its phosphorylation. Protein kinases AKT and MAP kinase, as well as protein phosphatase calcineurin were found to be involved in the regulation of BCL2 associated agonist of cell death. Alternative splicing of BAD results in two transcript variants which encode the same isoform.

Introducing the Phospho-Bad (S155) Polyclonal Antibody, a cutting-edge scientific tool meticulously designed to facilitate advanced research in the field of cellular signaling pathways. This antibody, developed with utmost precision and expertise, specifically targets the phosphorylated form of Bad at serine 155 residue, enabling researchers to delve into the intricate mechanisms underlying cellular processes.

Crafted with the highest quality materials and adhering to rigorous manufacturing standards, this polyclonal antibody exhibits exceptional specificity and sensitivity, ensuring accurate and reliable results. Its unique formulation allows for optimal recognition and binding to the phosphorylated Bad (S155) epitope, thereby facilitating the detection and analysis of this critical protein modification.

The Phospho-Bad (S155) Polyclonal Antibody serves as an indispensable tool for elucidating the role of Bad phosphorylation in various cellular events, including apoptosis, cell survival, and metabolism. By selectively targeting the phosphorylated form of Bad, researchers can gain valuable insights into the intricate regulatory mechanisms governing these fundamental processes.

This antibody's versatility extends to a wide range of applications, including Western blotting, immunoprecipitation, immunofluorescence, and immunohistochemistry. Its compatibility with multiple experimental techniques empowers researchers to explore the phosphorylation status of Bad (S155) across diverse biological samples and experimental conditions, thereby broadening the scope of scientific investigations.

Furthermore, the Phospho-Bad (S155) Polyclonal Antibody exhibits exceptional reproducibility and consistency, ensuring reliable and robust results across experiments. Its superior performance characteristics, coupled with its ease of use, make it an invaluable asset for both seasoned researchers and newcomers in the field.

In summary, the Phospho-Bad (S155) Polyclonal Antibody represents a breakthrough in scientific research, offering an unparalleled opportunity to unravel the complexities of cellular signaling pathways. With its exceptional specificity, sensitivity, and versatility, this antibody is poised to revolutionize investigations into the role of Bad phosphorylation, ultimately advancing our understanding of cellular processes and paving the way for groundbreaking discoveries.